Trials / Withdrawn
WithdrawnNCT00583206
Muscle Atrophy in Sepsis
Biochemical Pathways to Skeletal Muscle Atrophy in Human Sepsis
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Gregory A. Schmidt · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Severe sepsis will provoke signals leading to muscle atrophy and weakness. Electrical stimulation will reduce the impact of sepsis.
Detailed description
Hypothesis 1: Severe sepsis will be associated with downregulation of anabolic signaling molecules and genes, upregulation of catabolic signaling molecules and genes, and the development of histologic and electrophysiologic abnormalities within skeletal muscle. Hypothesis 2: Electrical stimulation will improve muscle strength in patients with sepsis. Hypothesis 3: Electrical stimulation will be associated with upregulation of anabolic signaling molecules and genes, downregulation of catabolic signaling molecules and genes, and improvement of histologic and electrophysiologic parameters within skeletal muscle of patients with sepsis. Hypothesis 4: The ratio of catabolic:anabolic gene expression on Day 3 will be positively correlated with the severity of clinical weakness on Day 7
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2007-12-31
- Last updated
- 2017-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00583206. Inclusion in this directory is not an endorsement.